INNOVA CAPTAB LTD. share price has zoomed 10% and is presently trading at Rs 1,125.3.
Meanwhile, the BSE HEALTHCARE index is at 44,089.8 (up 1.0%).
Among the top gainers in the BSE HEALTHCARE index today are Natco Pharma (up 3.7%) and APOLLO HOSPITALS (up 3.1%).
Jubilant Pharmova (down 2.7%) and GSK Pharma (down 1.9%) are among the top losers today.
Over the last one year, INNOVA CAPTAB LTD. has moved up from Rs 0.0 to Rs 1,125.3, registering a gain of Rs 1,125.3 .
On the other hand, the BSE HEALTHCARE index has moved up from 29,654.9 to 44,089.8, registering a gain of 48.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 177.6%), SUVEN PHARMACEUTICALS (up 103.5%) and Glenmark Pharma (up 100.7%).
End of Year Sale: Save Rs 6,050 on our small cap research
The BSE Sensex is at 79,882.5 (up 0.1%).
The top gainers among the BSE Sensex today are Ultratech Cement (up 4.7%) and M&M (up 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,172.7 (up 0.2%). Ultratech Cement and Grasim Industries are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,174.2 to 79,882.5, registering a gain of 13,708.3 points (up 20.7%).
INNOVA CAPTAB LTD. net profit grew 52.8% YoY to Rs 350 million for the quarter ended September 2024, compared to a profit of Rs 229 million a year ago. Net sales rose 12.5% to Rs 3,182 million during the period as against Rs 2,829 million in July-September 2023.
For the year ended March 2024, INNOVA CAPTAB LTD. reported 38.8% increase in net profit to Rs 943 million compared to net profit of Rs 680 million during FY23. Revenue of the company grew 16.7% to Rs 10,813 million during FY24.
The current Price to earnings ratio of INNOVA CAPTAB LTD., based on rolling 12 month earnings, stands at 54.4.
Equitymaster requests your view! Post a comment on "INNOVA CAPTAB LTD. Gains 10%; BSE HEALTHCARE Index Up 1.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!